Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

Article  PubMed  Google Scholar 

Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC. Tumour ‘budding’ as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology. 2002;40(2):127–32.

Article  CAS  PubMed  Google Scholar 

Lugli A, Kirsch R, Ajioka Y, Bosman F, Cathomas G, Dawson H, El Zimaity H, Fléjou JF, Hansen TP, Hartmann A, et al. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Mod Pathol. 2017;30(9):1299–311.

Article  PubMed  Google Scholar 

Lugli A, Karamitopoulou E, Zlobec I. Tumour budding: a promising parameter in colorectal cancer. Br J Cancer. 2012;106(11):1713–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mitrovic B, Schaeffer DF, Riddell RH, Kirsch R. Tumor budding in colorectal carcinoma: time to take notice. Mod Pathol. 2012;25(10):1315–25.

Article  CAS  PubMed  Google Scholar 

Takeya M, Komohara Y. Role of tumor-associated macrophages in human malignancies: friend or foe? Pathol Int. 2016;66(9):491–505.

Article  PubMed  Google Scholar 

Edin S, Wikberg ML, Dahlin AM, Rutegård J, Öberg Å, Oldenborg PA, Palmqvist R. The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PLoS ONE. 2012;7(10): e47045.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Wei C, Yang C, Wang S, Shi D, Zhang C, Lin X, Liu Q, Dou R, Xiong B. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. Mol Cancer. 2019;18(1):64.

Article  PubMed  PubMed Central  Google Scholar 

Yin Y, Yao S, Hu Y, Feng Y, Li M, Bian Z, Zhang J, Qin Y, Qi X, Zhou L, et al. The Immune-microenvironment confers chemoresistance of colorectal cancer through macrophage-derived IL6. Clin Cancer Res. 2017;23(23):7375–87.

Article  CAS  PubMed  Google Scholar 

Zhang X, Chen Y, Hao L, Hou A, Chen X, Li Y, Wang R, Luo P, Ruan Z, Ou J, et al. Macrophages induce resistance to 5-fluorouracil chemotherapy in colorectal cancer through the release of putrescine. Cancer Lett. 2016;381(2):305–13.

Article  CAS  PubMed  Google Scholar 

Chen J, Wang H, Jia L, He J, Li Y, Liu H, Wu R, Qiu Y, Zhan Y, Yuan Z, et al. Bufalin targets the SRC-3/MIF pathway in chemoresistant cells to regulate M2 macrophage polarization in colorectal cancer. Cancer Lett. 2021;513:63–74.

Article  CAS  PubMed  Google Scholar 

Komura D, Ishikawa S. Machine learning approaches for pathologic diagnosis. Virchows Arch. 2019;475(2):131–8.

Article  CAS  PubMed  Google Scholar 

Song JH, Hong Y, Kim ER, Kim SH, Sohn I. Utility of artificial intelligence with deep learning of hematoxylin and eosin-stained whole slide images to predict lymph node metastasis in T1 colorectal cancer using endoscopically resected specimens; prediction of lymph node metastasis in T1 colorectal cancer. J Gastroenterol. 2022;57(9):654–66.

Article  CAS  PubMed  Google Scholar 

Ohe R, Meng HX, Ye Aung N, Yamada A, Kabasawa T, Utsunomiya A, Tamazawa N, Tamura Y, Kitaoka T, Hashimoto T, et al. Differential expression of estrogen receptor-alpha on follicular dendritic cells from patients with grade 1–2 and grade 3 follicular lymphoma. Hematol Oncol. 2019;37(2):151–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ohe R, Yang S, Yamashita D, Ichikawa C, Saito A, Kabasawa T, Utsunomiya A, Aung NY, Urano Y, Kitaoka T, et al. Pathogenesis of follicular thymic hyperplasia associated with rheumatoid arthritis. Pathol Int. 2022;72(4):252–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Angius A, Scanu AM, Arru C, Muroni MR, Carru C, Porcu A, Cossu-Rocca P, De Miglio MR. A portrait of intratumoral genomic and transcriptomic heterogeneity at single-cell level in colorectal cancer. Medicina (Kaunas). 2021;57(11):1257.

Article  PubMed  PubMed Central  Google Scholar 

Suzuki Y, Ng SB, Chua C, Leow WQ, Chng J, Liu SY, Ramnarayanan K, Gan A, Ho DL, Ten R, et al. Multiregion ultra-deep sequencing reveals early intermixing and variable levels of intratumoral heterogeneity in colorectal cancer. Mol Oncol. 2017;11(2):124–39.

Article  CAS  PubMed  Google Scholar 

Boonsong A, Curran S, McKay JA, Cassidy J, Murray GI, McLeod HL. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases. Hum Pathol. 2002;33(11):1114–9.

Article  CAS  PubMed  Google Scholar 

Shaojun C, Li H, Haixin H, Guisheng L. Expression of topoisomerase 1 and carboxylesterase 2 correlates with irinotecan treatment response in metastatic colorectal cancer. Cancer Biol Ther. 2018;19(3):153–9.

Article  PubMed  PubMed Central  Google Scholar 

Tokunaga R, Xiu J, Johnston C, Goldberg RM, Philip PA, Seeber A, Naseem M, Lo JH, Arai H, Battaglin F, et al. Molecular profiling of appendiceal adenocarcinoma and comparison with right-sided and left-sided colorectal cancer. Clin Cancer Res. 2019;25(10):3096–103.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Merlino G, Fiascarelli A, Bigioni M, Bressan A, Carrisi C, Bellarosa D, Salerno M, Bugianesi R, Manno R, Bernado Morales C, et al. MEN1309/OBT076, a first-in-class antibody-drug conjugate targeting CD205 in solid tumors. Mol Cancer Ther. 2019;18(9):1533–43.

Article  CAS  PubMed  Google Scholar 

Ohe R, Aung NY, Tamura Y, Kabasawa T, Utsunomiya A, Tamazawa N, Kitaoka T, Meng HX, Shibata K, Yamakawa M. Diagnostic utility of CD205 in breast cancer: simultaneous detection of myoepithelial cells and dendritic cells in breast tissue by CD205. Histol Histopathol. 2020;35(5):481–8.

CAS  PubMed  Google Scholar 

Al-Tubuly AA, Spijker R, Pignatelli M, Kirkland SC, Ritter MA. Inhibition of growth and enhancement of differentiation of colorectal carcinoma cell lines by MAb MR6 and IL-4. Int J Cancer. 1997;71(4):605–11.

Article  CAS  PubMed  Google Scholar 

Trotsyuk I, Sparschuh H, Müller AJ, Neumann K, Kruschewski M, Horst D, Elezkurtaj S. Tumor budding outperforms ypT and ypN classification in predicting outcome of rectal cancer after neoadjuvant chemoradiotherapy. BMC Cancer. 2019;19(1):1033.

Article  PubMed  PubMed Central  Google Scholar 

Lee YF, Lee CY, Lai LC, Tsai MH, Lu TP, Chuang EY. Cell express: a comprehensive microarray-based cancer cell line and clinical sample gene expression analysis online system. Database (Oxford). 2018. https://doi.org/10.1093/database/bax101.

Article  PubMed  PubMed Central  Google Scholar 

Ueno H, Ishiguro M, Nakatani E, Ishikawa T, Uetake H, Matsuda C, Nakamoto Y, Kotake M, Kurachi K, Egawa T, et al. Prospective multicenter study on the prognostic and predictive impact of tumor budding in stage II colon cancer: results from the SACURA trial. J Clin Oncol. 2019;37(22):1886–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Galván JA, Helbling M, Koelzer VH, Tschan MP, Berger MD, Hädrich M, Schnüriger B, Karamitopoulou E, Dawson H, Inderbitzin D, et al. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial–mesenchymal transition-like tumor budding phenotype in colorectal cancer. Oncotarget. 2015;6(2):874–85.

Article  PubMed  Google Scholar 

Marusyk A, Polyak K. Tumor heterogeneity: causes and consequences. Biochim Biophys Acta. 2010;1805(1):105–17.

CAS  PubMed  Google Scholar 

Zanoni M, Pegoraro A, Adinolfi E, De Marchi E. Emerging roles of purinergic signaling in anti-cancer therapy resistance. Front Cell Dev Biol. 2022;10:1006384.

Article  PubMed  PubMed Central  Google Scholar 

Lu J. The Warburg metabolism fuels tumor metastasis. Cancer Metastasis Rev. 2019;38(1–2):157–64.

Article  MathSciNet  CAS  PubMed  Google Scholar 

Tan K, Naylor MJ. Tumour microenvironment-immune cell interactions influencing breast cancer heterogeneity and disease progression. Front Oncol. 2022;12: 876451.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gurzu S, Silveanu C, Fetyko A, Butiurca V, Kovacs Z, Jung I. Systematic review of the old and new concepts in the epithelial–mesenchymal transition of colorectal cancer. World J Gastroenterol. 2016;22(30):6764–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yamada N, Sugai T, Eizuka M, Tsuchida K, Sugimoto R, Mue Y, Suzuki M, Osakabe M, Uesugi N, Ishida K, et al. Tumor budding at the invasive front of colorectal cancer may not be associated with the epithelial–mesenchymal transition. Hum Pathol. 2017;60:151–9.

Article  CAS  PubMed  Google Scholar